• SENSEX
    NIFTY 50
Healthcare

OAI letter from USFDA for Lupin's Mandideep facility won't impact future earnings, says HDFC Sec

Updated : March 14, 2019 09:50 AM IST

The US Food and Drug Administration (USFDA) has classified the inspection at Lupin's Mandideep facility in Madhya Pradesh (MP) as 'official action indicated'.
New approvals from this unit may be withheld.

You May Also Like

Live TV
Advertisement